Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Lichen planopilaris can occur with multiple autoimmune diseases.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Yellow and orange colors are important for diagnosing certain skin conditions.